TAO Synergies Inc. (TAOX)
Oxford Ledge is still expanding full research coverage of TAOX. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
TAO Synergies transitioned from a biopharmaceutical company to pursue a cryptocurrency treasury strategy focused on staking TAO tokens within the Bittensor blockchain network.
SEC filings
- 10-K/A Amended annual report 2026-06-05
- 10-Q Quarterly financial report (unaudited) 2026-05-13
- 10-K Annual financial report with audited statements 2026-03-31
- 8-K Departure/election of directors or officers; Shareholder vote results; Financial statements and exhibits 2025-12-19
- DEF 14A Proxy statement for shareholder vote 2025-11-17
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for TAOX. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open TAOX in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.